Human mucosal-associated invariant T (MAIT) cells are characterized by their expression of
an invariant TCR α chain Vα7. 2-Jα33/Jα20/Jα12 paired with a restricted TCR β chain. MAIT …

Allogeneic (allo) hematopoietic cell transplantation (HCT) is the only curative treatment
option for patients suffering from chemotherapy-refractory or relapsed hematological …

Microbial diversity is associated with improved outcomes in recipients of allogeneic
hematopoietic cell transplantation (allo-HCT), but the mechanism underlying this …

Chimeric antigen receptor (CAR) engineered T cell therapies individually prepared for each
patient with autologous T cells have recently changed clinical practice in the management of …

Gut acute graft-versus-host disease (aGVHD) is a serious complication after allogeneic
hematopoietic stem cell transplantation (allo-HSCT) and is associated with high mortality …

Mucosal-associated Invariant T (MAIT) cells recognize vitamin B-based antigens presented
by the non-polymorphic MHC class I related-1 molecule (MR1). Both MAIT T cell receptors …

Mucosal-associated invariant T (MAIT) cells are innate-like T cells present at considerable
frequencies in human blood and barrier tissues, armed with an expanding array of effector …

Mucosal associated invariant T (MAIT) cells are innate-like T lymphocytes, strikingly
enriched at mucosal surfaces and characterized by a semi-invariant αβ T cell receptor (TCR) …

Antimicrobial resistance is a serious threat to global public health as antibiotics are losing
effectiveness due to rapid development of resistance. The human immune system facilitates …

Human cytomegalovirus reactivation is a major opportunistic infection after allogeneic
haematopoietic stem cell transplantation and has a complex relationship with post …